Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/26/15 | $20,400,000 | Series A |
Aperture Venture Partners RiverVest Venture Partners Sante Ventures Third Point Ventures | undisclosed |
